MedTrace Logo

Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

NCT06363864 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-04-12

No results posted yet for this study

Summary

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Conditions

  • Metabolic Syndrome

Sponsors & Collaborators

  • Leeuwenhoek Laboratories Co. Ltd.

    lead INDUSTRY

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-14
Primary Completion
2029-10-31
Completion
2029-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06363864 on ClinicalTrials.gov